Hadassah

Hadassah Goes to Open-Air Market to Screen Smokers for COPD

Monday, Nov 23 2015

Handing out kits about Chronic Obstructive Pulmonary Disease (COPD).

Amidst the tomato, cheese, and halva stands in Jerusalem's open-air market, Machaneh  Yehuda, more than 150 shoppers and vendors were screened by Hadassah Medical Center lung specialists to see if they had Chronic Obstructive Pulmonary Disease (COPD).

The sign, which was used to attract shoppers, read: “Are you a smoker? Come and be tested by Hadassah lung experts to see if you are in danger of COPD.” It turned out that 25 individuals showed signs of the disease.

This was the first time Hadassah physicians went out into the community to test smokers for this serious condition, rather than inviting them to come to the hospital for screening. The initiative was part of Hadassah’s way of marking World COPD Awareness Day.

The screening aims to diagnosis the disease early and assess the person’s future risk of contracting it.  COPD, characterized by poor airflow and respiratory difficulties in the lungs, occurs almost exclusively in smokers. Early diagnosis of COPD can prevent the disease and its many complications, explains Prof. Neville Berkman, Director of Hadassah’s Institute of Pulmonology and head of its Adult and Invasive Pulmonology Unit. And, he says, the test and assessment together take only a few minutes!

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More